Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy

被引:6
|
作者
Pili-Floury, Sebastien [1 ,2 ,3 ]
Royer, Bernard [4 ,5 ]
Bartholin, Frederique [1 ]
Crumiere, Nathalie [1 ]
Combe, Marielle [1 ]
Chalopin, Jean-Marc [2 ,5 ,6 ]
Pivot, Xavier [2 ,5 ,7 ]
Heyd, Bruno [2 ,5 ,8 ]
Chauffert, Bruno [9 ]
Samain, Emmanuel [1 ,2 ,3 ]
机构
[1] CHU Besancon, Dept Anesthesiol & Intens Care Med, F-25000 Besancon, France
[2] Univ Franche Comte, F-25000 Besancon, France
[3] INSERM IFR 133, EA 3920, F-25000 Besancon, France
[4] CHU Besancon, Dept Pharmacol, F-25000 Besancon, France
[5] INSERM UMR 645, F-25000 Besancon, France
[6] CHU Besancon, Dept Nephrol, F-25000 Besancon, France
[7] CHU Besancon, Dept Oncol, F-25000 Besancon, France
[8] CHU Besancon, Dept Gen Surg, F-25000 Besancon, France
[9] Georges Francois Leclerc Ctr, Dept Oncol, F-21000 Dijon, France
关键词
Ovarian cancer; Intraperitoneal chemotherapy; Cisplatin; Epinephrine; Renal function; CYTOREDUCTIVE SURGERY; INTRAPERITONEAL CHEMOTHERAPY; OVARIAN-CANCER; NEPHROTOXICITY; FAILURE; FEASIBILITY; CARBOPLATIN; MORTALITY; CARCINOMA;
D O I
10.1016/j.ejogrb.2011.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Intra-operative cisplatin-based intra-peritoneal chemotherapy (IPC) may alter renal function in patients with advanced ovarian cancer. The aim of this study was to describe postoperative alteration of renal function after cisplatin-based IPC and to identify risk factors for moderate to severe acute renal failure. Study design: This prospective observational study was carried out on 77 consecutive patients who underwent cisplatin-based IPC procedures, with (n = 23) or without (n = 54) intra-peritoneal epinephrine, for advanced ovarian cancer. Postoperative renal function was assessed using serial serum creatinine measurements and was based on serum creatinine changes from pre-operative values, according to the risk, injury, failure, loss, end-stage kidney disease (RIFLE) classification. Patients were divided into two groups according to postoperative renal function: patients with renal injury or failure (IF group) or patients with no renal alteration or renal risk (NR group). Clinical variables were compared between the IF and NR groups using univariate and multivariate analysis. Results: Postoperative acute change in renal function was observed in 34 (44.2%) patients (unimodal distribution), among whom 23 patients (29.8%) constituted the IF group. In univariate analysis, the absence of epinephrine in the IPC bath, a higher duration of severe hypotension, a lower postoperative blood protein level, and a lower volume of intra-operative diuresis were significantly associated with the occurrence of renal injury or failure. In multivariate analysis, the absence of epinephrine was the only factor associated with the occurrence of moderate to severe acute renal failure (odds ratio [95% confidence interval] = 4.49 [1.36-14.80]). Conclusions: Transient acute renal dysfunction after cisplatin-based IPC associated with cytoreductive surgery is frequent and intra-peritoneal epinephrine plays a protective role. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [21] Particle Stability During Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC)
    Mikolajczyk, Agata
    Khosrawipour, Veria
    Schubert, Justyna
    Chaudhry, Haris
    Pigazzi, Alessio
    Khosrawipour, Tanja
    ANTICANCER RESEARCH, 2018, 38 (08) : 4645 - 4649
  • [22] Immune biomarkers associated with response to intra-peritoneal chemotherapy in ovarian cancer
    Simons, E.
    Kiet, T.
    Amanam, I.
    Ho, M.
    Fuh, J.
    Fuh, K.
    Kapp, D.
    Odunsi, K.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S141 - S141
  • [23] Colobronchial Fistula: An Unusual Complication after Peritonectomy and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)
    Laterza, Barbara
    Baratti, Dario
    Cozzi, Guido
    Kusamura, Shigeki
    Oliva, Grazia Daniela
    Gavazzi, Cecilia
    Fumagalli, Luca
    Sironi, Alessandro
    Sabia, Domenico
    Deraco, Marcello
    IN VIVO, 2009, 23 (01): : 151 - 153
  • [24] Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy
    Sutton, P. A.
    O'Dwyer, S. T.
    Barriuso, J.
    Aziz, O.
    Selvasekar, C. R.
    Renehan, A. G.
    Wilson, M. S.
    SURGICAL ONCOLOGY-OXFORD, 2021, 38
  • [25] ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases
    Daryl K. A. Chia
    Jia Jun Ang
    Raghav Sundar
    Guowei Kim
    Asim Shabbir
    Jimmy B. Y. So
    Wei Peng Yong
    Annals of Surgical Oncology, 2022, 29 : 8606 - 8607
  • [26] Impact of intra-peritoneal fat distribution on intra-operative bleeding volume with D2 lymphadenectomy in Chinese patients with gastric cancer
    Lv, Tian
    Beeharry, Maneesh Kumarsing
    Zhu, Zheng-Lun
    ASIAN JOURNAL OF SURGERY, 2019, 42 (07) : 768 - 774
  • [27] ALTERATIONS OF INTESTINAL AND RENAL FUNCTIONS IN RATS AFTER INTRA-PERITONEAL INJECTIONS OF LEAD ACETATE
    WAPNIR, RA
    MOAK, SA
    LIFSHITZ, F
    TEICHBERG, S
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1979, 94 (01): : 144 - 151
  • [28] ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases
    Chia, Daryl K. A.
    Ang, Jia Jun
    Sundar, Raghav
    Kim, Guowei
    Shabbir, Asim
    So, Jimmy B. Y.
    Yong, Wei Peng
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (13) : 8606 - 8607
  • [29] RB-86 DISTRIBUTION IN MICE AFTER INTRA-PERITONEAL APPLICATION
    STOLLAROVA, N
    MRAZ, L
    ISOTOPENPRAXIS, 1977, 13 (01): : 21 - 23
  • [30] Disposition of amiodarone in rats after single and multiple intra-peritoneal doses
    Tawfeeg A. O. Najjar
    European Journal of Drug Metabolism and Pharmacokinetics, 2000, 25 : 199 - 203